Literature DB >> 9505190

Biological and molecular characteristics of interleukin-5 and its receptor.

S Karlen1, M L De Boer, R J Lipscombe, W Lutz, V A Mordvinov, C J Sanderson.   

Abstract

Interleukin-5 (IL5) is a T cell-derived cytokine involved in the pathogenesis of atopic diseases. It specifically controls the production, the activation and the localization of Eosinophils. The Eosinophils are the major cause of tissue damage resulting in the symptoms of asthma and related allergic disorders. T cells purified from bronchoalveolar lavage and peripheral blood of asthmatics secrete elevated amount of IL5. Therefore IL5 emerges to be an attractive target for the generation of new anti-allergic drugs. Agents which inhibit either the production or the activity of IL5 could be expected to ameliorate the pathological effects of the allergic response. A better understanding of the biology of IL5 and the regulation of its expression is, however, a prerequisite for the development of new therapeutic agents. This review covers the major biological, molecular and structural aspects of IL5 research since the identification of this cytokine ten years ago.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505190     DOI: 10.3109/08830189809042996

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  10 in total

1.  DNase I footprinting of the human interleukin-5 gene promoter.

Authors:  D J Cousins; D Richards; D M Kemeny; S Romagnani; T H Lee; D Z Staynov
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation.

Authors:  Tetsuya Ishino; Udaya Pillalamarri; Dominick Panarello; Madhushree Bhattacharya; Cecilia Urbina; Stephanie Horvat; Sanjay Sarkhel; Bradford Jameson; Irwin Chaiken
Journal:  Biochemistry       Date:  2006-01-31       Impact factor: 3.162

3.  Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Authors:  Y Zhang; E Y Denkers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Neurocysticercosis: local and systemic immune-inflammatory features related to severity.

Authors:  Brenda Sáenz; Agnes Fleury; Anahí Chavarría; Marisela Hernández; José C Crispin; María I Vargas-Rojas; Gladis Fragoso; Edda Sciutto
Journal:  Med Microbiol Immunol       Date:  2011-06-23       Impact factor: 3.402

5.  A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes.

Authors:  D L Radu; N Noben-Trauth; J Hu-Li; W E Paul; C A Bona
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

6.  Activation of liver X receptor induces macrophage interleukin-5 expression.

Authors:  Yuanli Chen; Yajun Duan; Yanhua Kang; Xiaoxiao Yang; Meixiu Jiang; Ling Zhang; Guangliang Li; Zhinan Yin; Wenquan Hu; Pengzhi Dong; Xiaoju Li; David P Hajjar; Jihong Han
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

7.  Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.

Authors:  Delphine Giusti; Gregory Gatouillat; Sébastien Le Jan; Julie Plée; Philippe Bernard; Frank Antonicelli; Bach Nga Pham
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

8.  Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection.

Authors:  Matthew K O'Shea; Thomas E Fletcher; Julius Muller; Rachel Tanner; Magali Matsumiya; J Wendi Bailey; Jayne Jones; Steven G Smith; Gavin Koh; William G Horsnell; Nicholas J Beeching; James Dunbar; Duncan Wilson; Adam F Cunningham; Helen McShane
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 9.  Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics.

Authors:  Celeste M Porsbjerg; Asger Sverrild; Clare M Lloyd; Andrew N Menzies-Gow; Elisabeth H Bel
Journal:  Eur Respir J       Date:  2020-11-12       Impact factor: 16.671

10.  Proliferation and interleukin 5 production by CD8hi CD57+ T cells.

Authors:  Lee K Chong; Rebecca J Aicheler; Sian Llewellyn-Lacey; Peter Tomasec; Paul Brennan; Eddie C Y Wang
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.